"Du\u0161ek, L." . . "Screening karcinomu prsu, kolorekt\u00E1ln\u00EDho karcinomu a karcinomu hrdla d\u011Blo\u017En\u00EDho umo\u017E\u0148uje sn\u00ED\u017Eit popula\u010Dn\u00ED mortalitu t\u011Bchto onemocn\u011Bn\u00ED. Aby byl v\u0161ak skute\u010Dn\u011B zachov\u00E1n p\u0159\u00EDzniv\u00FD pom\u011Br mezi p\u0159\u00EDnosy a riziky plynouc\u00EDmi ze screeningov\u00E9ho programu aplikovan\u00E9ho na \u0161irokou populaci, je t\u0159eba zav\u00E9st a dodr\u017Eovat komplexn\u00ED standardy kvality p\u00E9\u010De. Screeningov\u00E9 programy by m\u011Bly b\u00FDt implementov\u00E1ny jako organizovan\u00E9 a popula\u010Dn\u00ED, se zaji\u0161t\u011Bn\u00EDm kvality na v\u0161ech \u00FArovn\u00EDch. C\u00EDlem tohoto p\u0159ehledov\u00E9ho \u010Dl\u00E1nku je p\u0159edstavit syst\u00E9m kontroly kvality v \u010Desk\u00FDch programech screeningu zhoubn\u00FDch n\u00E1dor\u016F a uv\u00E9st konkr\u00E9tn\u00ED p\u0159\u00EDklady indik\u00E1tor\u016F kvality vyu\u017Eiteln\u00FDch a vyu\u017E\u00EDvan\u00FDch v t\u011Bchto programech. Programy screeningu zhoubn\u00FDch n\u00E1dor\u016F v \u010CR jsou vybaveny komplexn\u00EDm informa\u010Dn\u00EDm z\u00E1zem\u00EDm, kter\u00E9 zahrnuje monitoring z\u00E1t\u011B\u017Ee populace zhoubn\u00FDmi n\u00E1dory, monitoring screeningov\u00E9ho procesu prost\u0159ednictv\u00EDm klinick\u00FDch dat a monitoring screeningov\u00E9ho procesu prost\u0159ednictv\u00EDm administrativn\u00EDch dat. Konkr\u00E9tn\u00ED indik\u00E1tory kvality popisuj\u00ED zejm. \u00FAsp\u011B\u0161nost n\u00E1b\u011Bru c\u00EDlov\u00E9 populace, schopnost screeningov\u00E9ho testu objevit (senzitivita) a vylou\u010Dit (specificita) hledan\u00E9 onemocn\u011Bn\u00ED, spr\u00E1vn\u00E9 vyu\u017E\u00EDv\u00E1n\u00ED n\u00E1sledn\u00E9 diagnostiky a p\u0159\u00EDpadn\u011B l\u00E9\u010Dby detekovan\u00FDch zhoubn\u00FDch n\u00E1dor\u016F nebo prekancer\u00F3z. V programu screeningu karcinomu prsu jsou tyto indik\u00E1tory rutinn\u011B vyu\u017E\u00EDv\u00E1ny pro monitoring jednotliv\u00FDch center, v programech screeningu kolorekt\u00E1ln\u00EDho karcinomu a karcinomu hrdla d\u011Blo\u017En\u00EDho jsou vyu\u017E\u00EDv\u00E1ny pro monitoring cel\u00E9ho programu a syst\u00E9m kontroly kvality jednotliv\u00FDch center je postupn\u011B vyv\u00EDjen. Od roku 2014 byl zah\u00E1jen projekt adresn\u00E9ho zvan\u00ED, kter\u00FD je v sou\u010Dasn\u00E9 dob\u011B ve spolupr\u00E1ci s N\u00E1rodn\u00EDm referen\u010Dn\u00EDm centrem a Ministerstvem zdravotnictv\u00ED \u010CR rovn\u011B\u017E pr\u016Fb\u011B\u017En\u011B vyhodnocov\u00E1n."@cs . "Indik\u00E1tory kvality screeningov\u00FDch program\u016F"@cs . "RIV/00216208:11110/14:10284538" . "[711F73D3E6A7]" . "7"^^ . . "11110" . "Performance Indicators in Screening Programmes"@en . "Screening karcinomu prsu, kolorekt\u00E1ln\u00EDho karcinomu a karcinomu hrdla d\u011Blo\u017En\u00EDho umo\u017E\u0148uje sn\u00ED\u017Eit popula\u010Dn\u00ED mortalitu t\u011Bchto onemocn\u011Bn\u00ED. Aby byl v\u0161ak skute\u010Dn\u011B zachov\u00E1n p\u0159\u00EDzniv\u00FD pom\u011Br mezi p\u0159\u00EDnosy a riziky plynouc\u00EDmi ze screeningov\u00E9ho programu aplikovan\u00E9ho na \u0161irokou populaci, je t\u0159eba zav\u00E9st a dodr\u017Eovat komplexn\u00ED standardy kvality p\u00E9\u010De. Screeningov\u00E9 programy by m\u011Bly b\u00FDt implementov\u00E1ny jako organizovan\u00E9 a popula\u010Dn\u00ED, se zaji\u0161t\u011Bn\u00EDm kvality na v\u0161ech \u00FArovn\u00EDch. C\u00EDlem tohoto p\u0159ehledov\u00E9ho \u010Dl\u00E1nku je p\u0159edstavit syst\u00E9m kontroly kvality v \u010Desk\u00FDch programech screeningu zhoubn\u00FDch n\u00E1dor\u016F a uv\u00E9st konkr\u00E9tn\u00ED p\u0159\u00EDklady indik\u00E1tor\u016F kvality vyu\u017Eiteln\u00FDch a vyu\u017E\u00EDvan\u00FDch v t\u011Bchto programech. Programy screeningu zhoubn\u00FDch n\u00E1dor\u016F v \u010CR jsou vybaveny komplexn\u00EDm informa\u010Dn\u00EDm z\u00E1zem\u00EDm, kter\u00E9 zahrnuje monitoring z\u00E1t\u011B\u017Ee populace zhoubn\u00FDmi n\u00E1dory, monitoring screeningov\u00E9ho procesu prost\u0159ednictv\u00EDm klinick\u00FDch dat a monitoring screeningov\u00E9ho procesu prost\u0159ednictv\u00EDm administrativn\u00EDch dat. Konkr\u00E9tn\u00ED indik\u00E1tory kvality popisuj\u00ED zejm. \u00FAsp\u011B\u0161nost n\u00E1b\u011Bru c\u00EDlov\u00E9 populace, schopnost screeningov\u00E9ho testu objevit (senzitivita) a vylou\u010Dit (specificita) hledan\u00E9 onemocn\u011Bn\u00ED, spr\u00E1vn\u00E9 vyu\u017E\u00EDv\u00E1n\u00ED n\u00E1sledn\u00E9 diagnostiky a p\u0159\u00EDpadn\u011B l\u00E9\u010Dby detekovan\u00FDch zhoubn\u00FDch n\u00E1dor\u016F nebo prekancer\u00F3z. V programu screeningu karcinomu prsu jsou tyto indik\u00E1tory rutinn\u011B vyu\u017E\u00EDv\u00E1ny pro monitoring jednotliv\u00FDch center, v programech screeningu kolorekt\u00E1ln\u00EDho karcinomu a karcinomu hrdla d\u011Blo\u017En\u00EDho jsou vyu\u017E\u00EDv\u00E1ny pro monitoring cel\u00E9ho programu a syst\u00E9m kontroly kvality jednotliv\u00FDch center je postupn\u011B vyv\u00EDjen. Od roku 2014 byl zah\u00E1jen projekt adresn\u00E9ho zvan\u00ED, kter\u00FD je v sou\u010Dasn\u00E9 dob\u011B ve spolupr\u00E1ci s N\u00E1rodn\u00EDm referen\u010Dn\u00EDm centrem a Ministerstvem zdravotnictv\u00ED \u010CR rovn\u011B\u017E pr\u016Fb\u011B\u017En\u011B vyhodnocov\u00E1n." . . . "Indik\u00E1tory kvality screeningov\u00FDch program\u016F"@cs . "CZ - \u010Cesk\u00E1 republika" . "I, V" . "Klinick\u00E1 onkologie" . "health care quality indicators; mass screening; cancer"@en . "Indik\u00E1tory kvality screeningov\u00FDch program\u016F" . "Ngo, O." . . . "2"^^ . "10.14735/amko20142S106" . . "21194" . "Indik\u00E1tory kvality screeningov\u00FDch program\u016F" . . "27" . . "Breast, colorectal and cervical cancer screening programmes make it possible to decrease the population mortality rates of these diseases. However, complex standards of the quality of care must be introduced and followed in order to maintain a favourable ratio between the benefits and risks arising from population- wide screening programmes. Such programmes should be organized and population-based, ensuring that quality control is performed at all levels. This review introduces the system of quality control in the Czech cancer screening programmes, and provides specific examples of performance indicators that are usable and/ or being used in these programmes. Cancer screening programmes in the Czech Republic are equipped with a comprehensive information background which involves monitoring of the cancer burden in the population, monitoring of the screening process based on clinical data, and monitoring of the screening process based on administrative data. In particular, the specific performance indicators describe the success rate of take-up of the target population, ability of the screening test to reveal (sensitivity) or to exclude (specificity) the screened condition, correct employment of subsequent diagnostic methods or treatment of detected cancers or precancerous lesions where applicable. In the Czech breast cancer screening programme, these indicators are routinely used in order to monitor the individual centres; in both colorectal and cervical cancer screening programmes, these indicators are used to monitor the entire programme, whereas the system of quality control for individual centres is under continuous development. A project of personalized invitations was launched in 2014, and its results are regularly evaluated in cooperation with the Czech National Reference Centre and the Ministry of Health of the Czech Republic."@en . "Suppl. 2" . . "0862-495X" . "Dvo\u0159\u00E1k, V." . "Performance Indicators in Screening Programmes"@en . "7"^^ . . . "Dane\u0161, Jan" . . . "http://www.linkos.cz/files/klinicka-onkologie/190/4615.pdf" . "Zavoral, Miroslav" . "RIV/00216208:11110/14:10284538!RIV15-MSM-11110___" . "M\u00E1jek, Ond\u0159ej" . . . "Klime\u0161, D." .